Sentences with phrase «of macular edema»

DRCR.net researchers will continue to monitor the study participants for at least three years to obtain additional information about the safety and effectiveness of these macular edema treatments.

Hard exudates detected on the digital photographs were an accurate indicator of macular edema.

In the article, «Utility of Hard Exudates for the Screening of Macular Edema,» using digital photographs of the eye taken at the doctor's office or clinic, eye specialists can reliably detect «hard exudates» — a key early sign of diabetes - related macular edema, reports the new research by Jorge A. Cuadros, OD, PhD, of UC Berkeley School of Optometry and colleagues.

Not exact matches

VEGF inhibitors have been used for several years to treat diabetic macular edema, a swelling of the retina that can occur as blood leaks around it.

About 750,000 Americans with diabetic retinopathy have diabetic macular edema (DME) in which fluid leaks into the macula, the area of the retina used when looking straight ahead.

The finding could lead to the development of new drugs for wet macular degeneration and diabetic macular edema.

The anti-vascular endothelial growth factor drugs ranibizumab and aflibercept, used to treat vision loss from diabetic macular edema (DME), and approximately 20 to 30 times more expensive than bevacizumab, are not cost - effective for treatment of DME compared to bevacizumab unless their prices decrease substantially, according to a study published online by JAMA Ophthalmology.

The photos were sent over the Internet for review by eye specialists, who looked for hard exudates close to the line of sight as an indicator of clinically significant macular edema.

This macular edema is one of the most serious vision - threatening changes in the eyes of people with diabetes.

The dilated exams showed clinically significant macular edema in about 15 percent of patients.

In their study, Dr Cuadros and coauthors sought to determine whether hard exudates in clinic photographs are an accurate indicator of clinically significant macular edema in patients with diabetes.

Because Lucentis is commonly injected to treat diabetic macular edema (DME)-- a build - up of fluid in the center of the retina — the study permitted the use of Lucentis for DME in the laser group, if necessary.

Regeneron Pharmaceuticals this week reported positive results from two phase 3 trials of Eylea (aflibercept) injection for diabetic macular edema (DME).

Clearside Biomedical announced that a special formulation of triamcinolone acetonide showed good outcomes in patients with macular edema associated with non-infectious uveitis.

Clearside Biomedical announced that their proprietary formulation of triamcinolone acetonide (CLS - TA) improved vision in patients with macular edema from noninfectious uveitis.

These studies have indicated that repeated doses of anti-VEGF medications, such as ranibizumab, may prevent blood vessels from leaking fluid and causing macular edema.

If left untreated, about a quarter of people with diabetes eventually lose some of their vision from diabetic macular edema — a condition in which leaking blood vessels cause swelling in the center of the retina.

«These results indicate a treatment breakthrough for saving the vision of people with diabetic macular edema,» said Neil M. Bressler, M.D., chair of the DRCR.net and chief of the Retina Division at the Wilmer Eye Institute, Johns Hopkins University.

When these damaged blood vessels begin to leak fluid near the center of the retina, known as the macula, macular edema occurs.

The DRCR.net was founded in 2002 through a cooperative agreement with the National Institutes of Health to form a collaborative network dedicated to facilitating multicenter clinical research of diabetic retinopathy, diabetic macular edema and associated conditions.

«This comparative - effectiveness study demonstrated that a new treatment can protect and, in many cases, improve the vision of people with diabetic macular edema,» said NEI Director Paul A. Sieving, M.D., Ph.D..

Laser treatment of the retina has been the standard care for diabetic macular edema since an NEI - supported study in 1985 showed it to be beneficial.

• Refractive errors • Cataracts • Optic neuritis, an inflammation of the optic nerve • Retinal diseases, such as a retinal tear or detachment • Macular degeneration • Glaucoma • Conjunctivitis • Diabetic eye problems, such as diabetic retinopathy and diabetic maculaMacular degeneration • Glaucoma • Conjunctivitis • Diabetic eye problems, such as diabetic retinopathy and diabetic macularmacular edema

Additionally, the levels of beta - carotene and other eye nutrients in green beans help prevent macular degeneration, also reducing the risk of eye diseases in general, while red beans have a mild diuretic effect that can help alleviate edema.

Comparison of Ranibizumab and Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusions in Routine Clinical Practice.